A mechanism-based classification of pain in multiple sclerosis.
about
Trigeminal neuralgia: New classification and diagnostic grading for practice and researchSafety issues of current analgesics: an updatePathophysiology of spasticity: implications for neurorehabilitation.Mechanisms and pharmacology of neuropathic pain in multiple sclerosis.Activation of cannabinoid CB2 receptors reduces hyperalgesia in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.A Survey of Severity and Distribution of Musculoskeletal Pain in Multiple Sclerosis Patients; a Cross-Sectional Study.How to diagnose neuropathic pain? The contribution from clinical examination, pain questionnaires and diagnostic tests.Parkinson's disease related pain: a review of recent findings.Neuropathic pain in animal models of nervous system autoimmune diseases.Neurovascular unit in chronic pain.Depression, pain and quality of life in patients with amyotrophic lateral sclerosis: a cross-sectional study.Peripheral and Central Neuroinflammatory Changes and Pain Behaviors in an Animal Model of Multiple SclerosisMultiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE modelsSex differences in a mouse model of multiple sclerosis: neuropathic pain behavior in females but not males and protection from neurological deficits during proestrus.Neuropathic pain: diagnosis and treatment.Multiple sclerosis: basic knowledge and new insights in perioperative management.Osteoporosis and multiple sclerosis: risk factors, pathophysiology, and therapeutic interventions.Botulinum Toxin Treatment in Multiple Sclerosis-a Review.Behavioral assessment of neuropathic pain, fatigue, and anxiety in experimental autoimmune encephalomyelitis (EAE) and attenuation by interleukin-10 gene therapy.Prevalence of neuropathic pain in early multiple sclerosis.Increased multiple sclerosis relapses related to lower prevalence of pain.Phospholipase A2 is involved in galactosylsphingosine-induced astrocyte toxicity, neuronal damage and demyelination.A randomized, double-blind, placebo-controlled trial of duloxetine for the treatment of pain in patients with multiple sclerosis.Systematic assessment and characterization of chronic pain in multiple sclerosis patients.What role does multiple sclerosis play in the development of untreatable painful conditions?Quality of life among multiple sclerosis patients in Saudi Arabia.Longitudinal 7-year follow-up of chronic pain in persons with multiple sclerosis in the community.L-Acetyl-carnitine in Patients with Carpal Tunnel Syndrome: Effects on Nerve Protection, Hand Function and Pain.Botulinum Toxin for Central Neuropathic Pain.
P2860
Q26745858-5871F07A-0D6B-4441-B31A-CE982AB62E67Q26777293-20389910-5553-42EE-AD12-5C84A7A44A63Q34455092-508F9A0C-8D9A-4F42-8BC4-C200EEF28E7DQ35731415-56850EBC-0AF0-4744-9EC9-205F19293283Q35731427-BC538EB8-E817-412D-8AB5-5404471957B1Q35745861-2D3D3DE2-0BA6-4F11-82A2-C01B96F07B74Q35789456-EFA3A7F0-7BC9-45C4-B74A-CBCFB1400873Q36503306-2EF77D54-9AA1-4581-A24F-BBA25EFAA07BQ36869524-71B1AB97-8C81-490F-9D16-5A65FA202888Q36942721-0B6E0A04-0CCD-4A3E-BBE0-24C9C22D63ECQ37267129-7597378F-0AF1-4854-8E4C-07CACF6AE274Q37273370-BCC0EB7F-EBC3-4A1A-A461-CFBB1998911EQ37601317-90EAB32B-7458-4453-A784-08349CAC1452Q37681814-445A37D6-299A-4E8B-8D66-20FFD2C59364Q38099629-7268E6B9-6FFC-4C83-AE2B-4BD44F34DFC0Q38130445-61A25299-6266-4154-88CC-AB44B2FE68AAQ38215692-63A240AC-1ED0-43BC-A963-8CEFEBDC40ADQ38618854-0F9183A3-053D-4034-822B-4EAD28007853Q40749948-2895EBED-2CA8-441E-8B16-043CF967A611Q41203703-3F393200-117C-4138-88FE-4873120D8F62Q41560209-DBFA1F41-3C10-4E10-84D4-27FB6F736E7AQ46270187-E943370A-B0F0-4CCE-B1AF-9E54AFB53895Q46365444-33DB73AB-4165-4736-B15B-5510CDA612EDQ47336747-5074FAA5-F216-41BD-9BD1-9E2DBF039A98Q47403876-6B7A766B-D473-4191-8B38-A6D0B51F7CC8Q47745308-5999A2B0-6326-49C4-BF27-AAAAA93A391AQ48255538-611CAB7E-D8B0-49EE-AA97-8C39B808481BQ49196486-80A98584-4F6A-4F19-BF40-EE694BC3E9D6Q55498097-C6684CCC-E6A9-4DF9-B569-9980C9C390BE
P2860
A mechanism-based classification of pain in multiple sclerosis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A mechanism-based classification of pain in multiple sclerosis.
@ast
A mechanism-based classification of pain in multiple sclerosis.
@en
type
label
A mechanism-based classification of pain in multiple sclerosis.
@ast
A mechanism-based classification of pain in multiple sclerosis.
@en
prefLabel
A mechanism-based classification of pain in multiple sclerosis.
@ast
A mechanism-based classification of pain in multiple sclerosis.
@en
P2093
P2860
P1433
P1476
A mechanism-based classification of pain in multiple sclerosis.
@en
P2093
P2860
P2888
P304
P356
10.1007/S00415-012-6579-2
P577
2012-07-04T00:00:00Z
2013-02-01T00:00:00Z